ZNF837: A Potential Drug Target for Neurological Disorders (G116412)

Target Name: ZNF837

NCBI ID: G116412

ZNF837

Other Name(s): ZNF837 variant 2 | zinc finger protein 837 | Zinc finger protein 837 | Zinc finger protein 837, transcript variant 2 | ZN837_HUMAN

ZNF837: A Potential Drug Target for Neurological Disorders

ZNF837 (ZNF837 variant 2) is a protein that is expressed in various tissues of the human body, including the brain, heart, and gastrointestinal tract. It is a member of the ZNF family, which is known for its role in the development and maintenance of neural networks and neuronal circuits. ZNF837 has been shown to play a role in the regulation of neuronal communication and has been implicated in a number of neurological and psychiatric disorders.

One of the key features of ZNF837 is its ability to interact with several different signaling pathways, including the tyrosine signaling pathway. This pathway is involved in the regulation of a wide range of cellular processes, including cell growth, differentiation, and survival. ZNF837 has been shown to play a role in the regulation of tyrosine signaling in neurons, and has been shown to interact with several different tyrosine-regulated proteins.

Another important function of ZNF837 is its role in the regulation of the Wnt signaling pathway. This pathway is involved in the regulation of cell growth and differentiation, and is often disrupted in a variety of diseases, including cancer. ZNF837 has been shown to play a role in the regulation of Wnt signaling in stem cells and has been shown to interact with several different Wnt-regulated proteins.

In addition to its role in the regulation of tyrosine and Wnt signaling, ZNF837 has also been shown to play a number of other roles in the regulation of cellular processes. For example, it has been shown to play a role in the regulation of the Notch signaling pathway, which is involved in the regulation of cell growth and differentiation. ZNF837 has also been shown to interact with several different Notch-regulated proteins.

Given its involvement in a number of different signaling pathways, ZNF837 is an attractive target for drug development. Researchers have identified several potential drug compounds that can inhibit the activity of ZNF837, and are currently in the process of testing these compounds in a variety of animal models of disease. If ZNF837 is a drug target, these compounds may be used to treat a wide range of neurological and psychiatric disorders.

Protein Name: Zinc Finger Protein 837

Functions: May be involved in transcriptional regulation

The "ZNF837 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF837 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets